BrosMed Announced CE MDR Approval of Tiche™ 0.035”High Pressure PTA Balloon Dilatation Catheter
Release time:
2023-03-21
March 21, 2023- BrosMed today announced that it receives European Medical Device Regulation (MDR) certification for Tiche™ 0.035” High Pressure PTA Balloon Dilatation Catheter which is designed for the treatment of severely calcified peripheral vascular disease and challenging AV cases. It is the first MDR certificate of BrosMed and also a successful conformity assessment which set a precedent for the future.
March 21, 2023- BrosMed today announced that it receives European Medical Device Regulation (MDR) certification for Tiche™ 0.035” High Pressure PTA Balloon Dilatation Catheter which is designed for the treatment of severely calcified peripheral vascular disease and challenging AV cases. It is the first MDR certificate of BrosMed and also a successful conformity assessment which set a precedent for the future.
Following receiving FDA 510(k) clearance for Tiche™ in July 2022, the newly-granted CE Mark approval enables BrosMed Medical to accelerate business expansion in Europe.
Combining several technologies innovatively, Tiche™ has been developed to tackle physicians’ needs for an ultra-high-pressure balloon catheter in full range of sizes. The patented microcrystalline grid balloon technology is facilitated to provide high-pressure, non-compliant dilatation which concentrates force on the lesion and reduces the risk of overexpanding the vessel in a low-profile balloon. The twin layer balloon construction offers a rated burst pressure up to 24 atm. Additionally, the dual lumen shaft design will achieve rapid deflation time.
Tiche™ is available in a great variety of balloon diameters from 3.0 to 12.0mm, with usable shaft lengths of 40cm, 75cm, 120cm and 135cm to meet the clinical needs.
It is believed that the release of Tiche™ 0.035” PTA Balloon Dilatation Catheter in Europe will mark a new phase in BrosMed’s peripheral vascular intervention business globally. BrosMed is determined to develop innovative medical devices to enhance its contribution to patients worldwide.
For more information about Tiche™, please visit BrosMed website or contact us via e-mail: Sales@brosmed.com.
Contact Us to Become BrosMed Partner!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
Meet BrosMed at ESC Congress 2024
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
2024-08-15
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately. Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology.
2024-08-01
CTO&CHIP PCI – Insights from the clinical practice (Ⅱ)
July 30, 2024 @16:00-17:30 (Beijing Time) Join BrosMed Medical on Tuesday, July 30 for an enlightening discussion that unites cardiologists from Malaysia, China, India, Tunisia and Portugal, where clinical expertise harmoniously fuses with CTO&CHIP innovation. At this exclusive webinar, we’re orchestrating a confluence of valuable insights, drawing from the collective wisdom of seasoned interventional cardiologists.
2024-07-26
BrosMed Announced CE MDR Approval of New Generation PTA SC Balloon Dilatation Catheters
May 27, 2024- BrosMed announced that it receives European Medical Device Regulation (MDR) certification for the New Generation PTA SC Balloon Dilatation Catheters (Brand Name: Polux™ Pro 014, Minerva™ Pro 018 and Atropos™ Pro 035).
2024-05-27
Meet BrosMed at Leipzig Interventional Course (LINC 2024)
We’re excited to announce that BrosMed team will attend LINC 2024 from May 28th to 31th in Leipzig, Germany. Leipzig Interventional Course is an exciting event that bringing the global vascular community together. As a company committed to improving clinic outcomes through innovative medical devices, we look forward to connecting with industry experts, physicians, and partners at this premier conference.
2024-05-14
Webinar Invitation | Creating A Successful Endovascular Practice. Apr. 29
Date: April 29, 2024 Time: 17:00-19:10 (Korean Standard Time) 16:00-18:10 (Beijing Time) 16:00-18:10 (Malaysia Time) 11:00-13:10 (Moscow Standard Time) 11:00-13:10 (Egypt Standard Time)
2024-04-24